>Let's Connect

Join the conversation

Drop your email in the form below, and you will receive our medtech articles as soon as they're published.

Why Fast-Tracking Clinical Use can Slow your Medical Device Progress clinical strategy market driven innovation Mar 30, 2022

Clinical use is a significant milestone for most medical device companies. Investors often see this milestone as a significant de-risking activity – one that can come with valuation...

Continue Reading...
Which Path to Take – Consumer Product or Medical Device? market driven innovation technology development Mar 23, 2022

Written by Eric Sugalski

It’s a critical decision that defines your commercial strategy – but it’s one that is often taken without carefully weighing the pros and cons of each...

Continue Reading...
The IP Anchor Effect intellectual property market driven innovation technology development Mar 16, 2022

New technology is one of the primary drivers of growth in the medical device industry. Developing new tech can be long, iterative, and expensive -- so it is understandable that...

Continue Reading...
Is Clinical Data Enough to Drive Market Adoption? clinical strategy market driven innovation Mar 09, 2022

Written by Eric Sugalski and Ulrich Herken

“You need to show clinical evidence that your medical device provides a benefit.”

It's a common request that early medical...

Continue Reading...
The Paper 510(k) Strategy regulatory strategy Mar 02, 2022

Written by Eric Sugalski

Many medtech leaders are pressured by investors and others to rapidly achieve regulatory clearance with a product design that is not intended for the market. This...

Continue Reading...
Proof-of-Concept Pitfalls in Medtech market driven innovation technology development Feb 23, 2022

The phrase “proof-of-concept” (POC) is widely used and engrained in the accepted formula of innovation. Engineers, scientists, researchers, and instructors operate under this mantra...

Continue Reading...
Who Pays and Why? market driven innovation Feb 16, 2022

It’s a critical decision that defines your commercial strategy – one that affects your market time horizon, pricing, marketing claims, distribution strategy, and more. Who pays and why?...

Continue Reading...
How to build your healthcare economic story market driven innovation Feb 09, 2022

Whether you are an established OEM or a medtech startup, clearly understanding and articulating your healthcare economic story is a vital part of your go-to-market strategy. With healthcare...

Continue Reading...
5 Secrets to Actionable User Needs in Medtech market driven innovation regulatory strategy Feb 02, 2022

User Needs (UNs) are the foundational component of your Design History File (DHF). This single document should be the one that feeds design requirements, risk management, and the V&V process....

Continue Reading...
When MVP Goes Wrong in Medtech market driven innovation technology development Jan 26, 2022

Minimum viable product (MVP) is a strategy that has gained rapid and widespread acceptance among the startup community. Used effectively, it can be a compelling strategy to...

Continue Reading...
Why the Endpoint is actually the Starting Point in Medtech market driven innovation regulatory strategy Jan 19, 2022

When you are developing a new medical device, it is tempting to start by brainstorming, developing prototypes, and running demos for investors and others. But this approach will often lead you to a...

Continue Reading...
Why the Smallest Viable Market is what Really Matters in Medtech market driven innovation Jan 12, 2022

You have probably been told that you need the $1B market to attract investment in medtech. Yes, market size matters, but pursuing the monster market is not always the right move in medtech.

And...

Continue Reading...